Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea
Journal of Korean Medical Science
; : 1543-1552, 2010.
Article
in En
| WPRIM
| ID: wpr-44290
Responsible library:
WPRO
ABSTRACT
Despite the rarity in incidence and prevalence, gastrointestinal stromal tumor (GIST) has emerged as a distinct pathogenetic entity. And the clinical management of GIST has been evolving very rapidly due to the recent recognition of its oncogenic signal transduction pathway and the introduction of new molecular-targeted therapy. Successful management of GIST requires a multidisciplinary approach firmly based on accurate histopathologic diagnosis. However, there was no standardized guideline for the management of Korean GIST patients. In 2007, the Korean GIST study group (KGSG) published the first guideline for optimal diagnosis and treatment of GIST in Korea. As the second version of the guideline, we herein have updated recent clinical recommendations and reflected changes in diagnosis, surgical and medical treatments for more optimal clinical practice for GIST in Korea. We hope the guideline can be of help in enhancing the quality of diagnosis by members of the Korean associate of physicians involving in GIST patients's care and subsequently in achieving optimal efficacy of treatment.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Piperazines
/
Pyrimidines
/
Recurrence
/
Biomarkers, Tumor
/
Proto-Oncogene Proteins c-kit
/
Neoadjuvant Therapy
/
Gastrointestinal Stromal Tumors
/
Republic of Korea
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Guideline
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Journal of Korean Medical Science
Year:
2010
Type:
Article